Atrial natriuretic peptide and brain natriuretic peptide release in human essential hypertension

Clinical Laboratory

Volumn 55, Issue 3-4, 2009, Pages 120-127

  Soualmia, Hayet ^a   Ayadi, Ilhem ^a   Omar, Souheil ^a   Feki, Moncef ^a   Drissa, Habiba ^a   Mebazaa, Abderraouf ^a   Kaabachi, Naziha ^a  

^a LA RABTA HOSPITAL   (Tunisia)

Author keywords

Atrial natriuretic peptide; Brain natriuretic peptide; Essential hypertension; Natriuretic peptides

Indexed keywords

ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; HYDROCORTISONE; INSULIN; RENIN;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; HEART LEFT VENTRICLE HYPERTROPHY; HORMONE RESPONSE; HUMAN; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SYSTOLIC BLOOD PRESSURE;

ANALYSIS OF VARIANCE; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; ELECTROCARDIOGRAPHY; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; VASOCONSTRICTION; VASODILATION;

EID: 65649086829     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. De Bold AJ. Atrial natriuretic factor: A hormone produced by the heart. Science 1985; 230: 767-70.
2. Saito Y, Nakao K, Itoh H. Brain natriuretic peptide is a novel cardiac hormone. Biochem Biophys Res Commun 1989; 158: 360-8.
3. Kurtz A, Della Bruna R, Pfeilschifter J, Taugmer R, Bauer C. Atrial natriuretic peptide inhibits renin release from juxtaglome-rular cells by a GMP mediated process. Proc Natl Acad Sci USA 1986; 83: 4769-73.
4. Cuneo RC, Espiner EA, Nicholls MG, Yandle TG, Livesy JH. Effects of physiological levels of atrial natriuretic peptide on hormone secretion inhibition of angiotensin-induced aldosterone secretion and renin release in normal man. J Clin Endocrinol Metab 1987; 65: 765-72.
5. De Bold AJ, Ma KK, Zhang Y, De Bold ML, Bensimon M, Khoshbaten A. The physiological and pathophysiological modulation of the endocrine function of the heart. Can J Physiol Pharmacol 2001; 79: 705-14.
6. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature 1988; 332: 78-81.
7. Espiner EA, Richards AM, Yandle TG, Nicholls MG. Natriuretic hormones. Endocrinol Metab Clin North Am 1995; 24: 481-509.
8. Sagnella GA, Markandu ND, Shore AC, MacGregor GA. Raised circulating levels of atrial natriuretic peptides in essential hypertension. Lancet 1986; 1: 179-81.
9. Buckley MG, Markandu ND, Miller MA, Sagnella GA, MacGregor GA. Plasma concentration and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension. J Hum Hypertens 1993; 7: 245-50.
10. Garcia R, Thibauld T, Cantin M. Correlation between cardiac hypertrophy and plasma levels of atrial natriuretic factor in non spontaneous models of hypertension in the rat. Biochem Biophys Res Commun 1987; 145: 532-41.
11. Zachariah PK, Burnett JC, Ritter SG, Strong CG. Atrial natriuretic peptide in human essential hypertension. Myo Clin Proc 1987; 62: 782-6.
12. Nishikimi T, Yoshihara F, Morimoto A et al. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 1996; 28: 22-30.
13. Muscholl MW, Schunkert H, Muders F et al. Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension. Am Heart J 1998; 135: 58-66.
14. Irzmanski R, Banachi M, Piechoto M et al. Atrial and Brain Natriuretic peptide and endothelin 1 concentration in patients with idiopathic arterial hypertension: The dependence on the selected morphological parameters. Clin Exp Hypertens 2007; 29: 149-64.
15. Dessi-Fulgheri P, Palermo R, Di Noto G et al. High levels of plasma atrial natriuretic factor and impaired left ventricular diastolic function in hypertensives without left ventricular hypertrophy. J Hypertens 1992; 10: 161-5.
16. Pontremoli R, Bezante GP, Robaudo C et al. Cardiac diastolic abnormalities and atrial natriuretic factor in essential hypertension. Eur Heart J 1993; 14: 910-4.
17. Uusimaa P, Tokola H, Ylitalo A et al. Plasma B type natriuretic peptide reflects left ventricular hypertrophy and diastolic function in hypertension. Int J Cardiol 2004; 97: 251-6.
18. Arques S, Roux E, Sbragia P et al. Comparison of B type natriuretic peptide with left atrial enlargement by echocardiography for the diagnosis of new-onset congestive heart failure with a preserved left ventricular systolic function in the setting of long-standing hypertension. Int J Cardiol 2008; 128: 123-5.
19. Belluardo P, Cataliotti A, Bonaiuto L et al. Lack of activation of molecular forms of the BNP system in human grade 1 hypertension and relationship to cardiac hypertrophy. Am J Physiol Heart Circ Physiol 2006; 291: H1529-35.
20. Vasan RS, Benjamin EJ, Larson MG et al. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction. The Framingham Heart Study. Jama 2002; 288: 1252-9.
21. Nakamura M, Tanaka P, Yoneza S, Satou K, Nagano M, Hiramori K. The limited value of plasma B type natriuretic peptide for screening for left ventricular hypertrophy among hypertensive patients. Am J Hypertens 2003; 16: 1025-9.
22. Conen D, Zeller A, Pfisterer M, Martina B. Usefulness of B type natriuretic peptide and C-reactive protein in predicting the presence or absence of left ventricular hypertrophy in patients with systemic hypertension. Am J Cardiol 2006; 97: 249-52.
23. Zhang Y. Discoordinate re-expression of cardiac fetal genes in N (omega)-nitro-L-arginine methyl ester (L-Name) hypertension. Cardiovasc Res 2003; 57: 158-67.
24. Nakayama T, Soma M, Takahashi Y, Rehemudula D, Kanmatsuse K, Furuya K. Functional deletion mutation of the 5′-flanking region of type A human natriuretic peptide receptor gene and its association with essential hypertension and left ventricular hypertrophy in the Japanese. Circ Res 2000; 86: 841-5.
25. Rubattu S, Bigatti G, Evangelista A, Lanzani C, Stanzione R, Zagato L et al. Association of atrial natriuretic peptide and type A natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension. J Am Coll Cardiol 2006; 48: 499-505.
26. Xue H, Wang S, Wang H et al. Atrial natriuretic peptide gene promoter polymorphism is associated with left ventricular hypertrophy in hypertension. Ciin Sci 2008; 114: 131-7.
27. Sahn DJ, DeMaria A, Kissolo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of survey of echocardiographic measurements. Circulation 1978; 58: 1072-83.
28. John SW, Krege JH, Oliver PM et al. Genetic decreases in atrial natriuretic peptide and salt - sensitive hypertension. Sciences 1995; 267: 679-81.
29. Ogawa Y, Itoh H, Tamura N et al. Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene. J Clin Invest 1994; 93: 1911-21.
30. Steinhelper ME, Cochrane KL, Field LJ. Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes. Hypertension 1990; 16: 301-7.
31. Lopez MJ, Wong SKF, Kishimoto I et al. Salt-resistant hypertension in mice lacking guanylyl cyclase A receptor for atrial natriuretic peptide. Nature 1995; 378: 65-8.
32. McGregor A, Richards M, Espiner E, Yandle T, Ikram H. Brain natriuretic peptide administered to man: actions and metabolism. J Clin Endocrinoi Metab 1990; 70: 1103-7.
33. Williamson JR, Holmberg SW, Chang K, Marvel J, Sutera S, Needleman P. Mechanisms underlying atriopeptin induced increases in haematocrit and vascular permeation in rats. Circ Res 1989; 64: 890-9.
34. Holmes SJ, Espiner EA, Richards AM, Yandle TG, Frampton C. Renal, endocrine and hemodynamic effects of human brain natriuretic peptide in normal man. J Clin Endocrinol Metab 1993; 76: 91-6.
35. Richards AM, Crozier IG, Homes SJ, Espiner EA, Yandle TG, Frampton C. Brain netriuretic peptide: natriuretic and endocrine effects in essential hypertension. J Hypertens 1993; 11: 163-70.